Bard Financial Services Inc. decreased its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 6.2% in the third quarter, HoldingsChannel.com reports. The fund owned 70,486 shares of the company’s stock after selling 4,625 shares during the period. Procter & Gamble comprises approximately 1.4% of Bard Financial Services Inc.’s investment portfolio, making the stock its 13th biggest holding. Bard Financial Services Inc.’s holdings in Procter & Gamble were worth $12,208,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Acorn Creek Capital LLC raised its holdings in Procter & Gamble by 2.8% in the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after acquiring an additional 59 shares during the last quarter. Patrick M Sweeney & Associates Inc. grew its stake in shares of Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after buying an additional 59 shares during the period. Hudson Value Partners LLC grew its stake in shares of Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after buying an additional 60 shares during the period. Traveka Wealth LLC grew its stake in shares of Procter & Gamble by 1.7% during the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after buying an additional 60 shares during the period. Finally, Allen Mooney & Barnes Investment Advisors LLC boosted its position in Procter & Gamble by 0.7% during the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock worth $1,507,000 after purchasing an additional 61 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Analyst Upgrades and Downgrades
PG has been the subject of a number of research reports. DA Davidson raised shares of Procter & Gamble from a “neutral” rating to a “buy” rating and upped their price target for the stock from $160.00 to $209.00 in a research report on Monday, November 25th. Morgan Stanley upped their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research note on Friday, November 22nd. Finally, DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective on the stock in a research note on Thursday, August 29th. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $180.45.
Procter & Gamble Trading Down 0.1 %
Shares of PG stock opened at $172.13 on Wednesday. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $180.43. The company has a market capitalization of $405.37 billion, a P/E ratio of 29.72, a P/E/G ratio of 3.68 and a beta of 0.44. The firm has a 50-day moving average price of $170.71 and a 200 day moving average price of $169.44. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period last year, the firm posted $1.83 EPS. The firm’s quarterly revenue was down .6% on a year-over-year basis. Research analysts forecast that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.34%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 69.48%.
Insiders Place Their Bets
In other news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. The trade was a 52.53 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 83,080 shares of company stock valued at $14,629,038. Insiders own 0.18% of the company’s stock.
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- There Are Different Types of Stock To Invest In
- The Great CPU Race: AMD and Intel Battle for Dominance
- Market Cap Calculator: How to Calculate Market Cap
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- What is Insider Trading? What You Can Learn from Insider Trading
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.